Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:763-772
Published online before print February 5, 2007, doi: 10.1161/CIRCULATIONAHA.106.664862
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/6/763    most recent
CIRCULATIONAHA.106.664862v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, Y.
Right arrow Articles by O’Connell, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, Y.
Right arrow Articles by O’Connell, T. D.
Related Collections
Right arrow Apoptosis
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies
Right arrow Receptor pharmacology

(Circulation. 2007;115:763-772.)
© 2007 American Heart Association, Inc.


Molecular Cardiology

An {alpha}1A-Adrenergic–Extracellular Signal-Regulated Kinase Survival Signaling Pathway in Cardiac Myocytes

Yuan Huang, MD; Casey D. Wright, PhD; Chastity L. Merkwan, BSc; Nichole L. Baye, BSc; Qiangrong Liang, MD, PhD; Paul C. Simpson, MD; Timothy D. O’Connell, PhD

From the Cardiovascular Research Institute at Sanford Research/USD and the Department of Medicine at The University of South Dakota School of Medicine, Sioux Falls, SD (Y.H., C.D.W., C.M., N.L.B., Q.L., T.D.O.), and the Cardiology Division, San Francisco Veterans Affairs Medical Center and the Cardiovascular Research Institute and Department of Medicine at The University of California at San Francisco, San Francisco (P.C.S.).

Correspondence to Timothy D. O’Connell, PhD, Cardiovascular Research Institute, Sanford Research/USD, Department of Medicine, The University of South Dakota, 1100 E 21st St, Suite 700, Sioux Falls, SD 57105. E-mail toconnel{at}usd.edu

Received September 15, 2006; accepted December 11, 2006.

Background— In {alpha}1-AR knockout ({alpha}1ABKO) mice that lacked cardiac myocyte {alpha}1-adrenergic receptor ({alpha}1-AR) binding, aortic constriction induced apoptosis, dilated cardiomyopathy, and death. However, it was unclear whether these effects were attributable to a lack of cardiac myocyte {alpha}1-ARs and whether the {alpha}1A, {alpha}1B, or both subtypes mediated protection. Therefore, we investigated {alpha}1A and {alpha}1B subtype–specific survival signaling in cultured cardiac myocytes to test for a direct protective effect of {alpha}1-ARs in cardiac myocytes.

Methods and Results— We cultured {alpha}1ABKO myocytes and reconstituted {alpha}1-AR signaling with adenoviruses expressing {alpha}1-GFP fusion proteins. Myocyte death was induced by norepinephrine, doxorubicin, or H2O2 and was measured by annexin V/propidium iodide staining. In {alpha}1ABKO myocytes, all 3 stimuli significantly increased apoptosis and necrosis. Reconstitution of the {alpha}1A subtype, but not the {alpha}1B, rescued {alpha}1ABKO myocytes from cell death induced by each stimulus. To address the mechanism, we examined {alpha}1-AR activation of extracellular signal-regulated kinase (ERK). In {alpha}1ABKO hearts, aortic constriction failed to activate ERK, and in {alpha}1ABKO myocytes, expression of a constitutively active MEK1 rescued {alpha}1ABKO myocytes from norepinephrine-induced death. In addition, only the {alpha}1A-AR activated ERK in {alpha}1ABKO myocytes, and expression of a dominant-negative MEK1 completely blocked {alpha}1A survival signaling in {alpha}1ABKO myocytes.

Conclusions— Our results demonstrate a direct protective effect of the {alpha}1A subtype in cardiac myocytes and define an {alpha}1A-ERK signaling pathway that is required for myocyte survival. Absence of the {alpha}1A-ERK pathway can explain the failure to activate ERK after aortic constriction in {alpha}1ABKO mice and can contribute to the development of apoptosis, dilated cardiomyopathy, and death.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. M. Perez, R. S. Papay, and T. Shi
{alpha}1-Adrenergic Receptor Stimulates Interleukin-6 Expression and Secretion through Both mRNA Stability and Transcriptional Regulation: Involvement of p38 Mitogen-Activated Protein Kinase and Nuclear Factor-{kappa}B
Mol. Pharmacol., July 1, 2009; 76(1): 144 - 152.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Copik, C. Ma, A. Kosaka, S. Sahdeo, A. Trane, H. Ho, P. S. Dietrich, H. Yu, A. P. D. W. Ford, D. Button, et al.
Facilitatory Interplay in {alpha}1a and {beta}2 Adrenoceptor Function Reveals a Non-Gq Signaling Mode: Implications for Diversification of Intracellular Signal Transduction
Mol. Pharmacol., March 1, 2009; 75(3): 713 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. O. Rybin, J. Guo, Z. Gertsberg, S. J. Feinmark, and S. F. Steinberg
Phorbol 12-Myristate 13-Acetate-dependent Protein Kinase C{delta}-Tyr311 Phosphorylation in Cardiomyocyte Caveolae
J. Biol. Chem., June 27, 2008; 283(26): 17777 - 17788.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. Banyasz, I. Lozinskiy, C. E. Payne, S. Edelmann, B. Norton, B. Chen, Y. Chen-Izu, L. T. Izu, and C. W. Balke
Transformation of adult rat cardiac myocytes in primary culture
Exp Physiol, March 1, 2008; 93(3): 370 - 382.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. P. Morris, B. Lei, Y.-X. Wu, G. A. Michelotti, and D. A. Schwinn
The {alpha}1a-Adrenergic Receptor Occupies Membrane Rafts with Its G Protein Effectors but Internalizes via Clathrin-coated Pits
J. Biol. Chem., February 1, 2008; 283(5): 2973 - 2985.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Woodcock, X.-J. Du, M. E. Reichelt, and R. M. Graham
Cardiac {alpha}1-adrenergic drive in pathological remodelling
Cardiovasc Res, February 1, 2008; 77(3): 452 - 462.
[Abstract] [Full Text] [PDF]